- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.11. | RAPID MICRO BIOSYSTEMS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 02.11. | Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2024 Earnings Call Transcript | 2 | Insider Monkey | ||
| 01.11. | Quartalsbericht: Rapid Micro Biosystems verzeichnet Rekordumsatz im dritten Quartal und strebt weiteres Wachstum an | 1 | Investing.com Deutsch | ||
| 01.11. | Earnings call: Rapid Micro Biosystems reports record Q3 revenue, eyes growth | 1 | Investing.com | ||
| 01.11. | Aktie von Rapid Micro Biosystems erreicht 52-Wochen-Hoch bei 1,18 US-Dollar | 1 | Investing.com Deutsch | ||
| 01.11. | Rapid Micro Biosystems stock hits 52-week high at $1.18 | 1 | Investing.com | ||
| 01.11. | Rapid Micro Biosystems GAAP EPS of -$0.26 in-line, revenue of $7.6M beats by $1.05M | 2 | Seeking Alpha | ||
| RAPID MICRO BIOSYSTEMS Aktie jetzt für 0€ handeln | |||||
| 01.11. | Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results | 67 | GlobeNewswire (Europe) | Reports record third quarter 2024 revenue of $7.6 million, representing growth of 24% compared to the third quarter of 2023Placed seven Growth Direct® systems in the third quarter of 2024, marking... ► Artikel lesen | |
| 01.11. | RAPID MICRO BIOSYSTEMS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.10. | Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024 | 1 | GlobeNewswire (USA) | ||
| 03.09. | Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 08.08. | Rapid Micro Biosystems CFO acquires $7.8k in company stock | 1 | Investing.com | ||
| 03.08. | Earnings call: Rapid Micro Biosystems surpassed their own guidance with a 32% increase in total revenue | 1 | Investing.com | ||
| 02.08. | RAPID MICRO BIOSYSTEMS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 02.08. | Rapid Micro Biosystems reports mixed Q2 results; reaffirms FY24 outlook | 1 | Seeking Alpha | ||
| 02.08. | Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results | 1.522 | GlobeNewswire (Europe) | Record second quarter 2024 revenue of $6.6 million, representing growth of 32% compared to the second quarter of 2023150th Growth Direct® system placed with an existing top 15 global pharma customer... ► Artikel lesen | |
| 02.08. | RAPID MICRO BIOSYSTEMS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.07. | Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024 | 1 | GlobeNewswire (USA) | ||
| 03.05. | Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Reports First Quarter 2024 Financial Results | 688 | GlobeNewswire (Europe) | Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million, representing... ► Artikel lesen | |
| 07.03. | Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 141 | GlobeNewswire (Europe) | LOWELL, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation... ► Artikel lesen |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EPIGENOMICS | 0,900 | -21,74 % | EQS-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Epigenomics AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Epigenomics AG: Vorabbekanntmachung über die... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,384 | +3,78 % | Defence Therapeutics Inc.: Defence Therapeutics Announces Securities for Debenture Financing | Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company... ► Artikel lesen | |
| GINKGO BIOWORKS | 6,000 | -0,83 % | Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Drop in Short Interest | ||
| RECURSION PHARMACEUTICALS | 5,860 | -2,98 % | Recursion Pharmaceuticals, Inc.: Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery | Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will... ► Artikel lesen | |
| BEAM THERAPEUTICS | 24,530 | +0,20 % | Beam Therapeutics Inc. (NASDAQ:BEAM) Sees Large Increase in Short Interest | ||
| ONCOLYTICS BIOTECH | 0,945 | 0,00 % | Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2024 Earnings Call Transcript | ||
| ARCTURUS THERAPEUTICS | 16,220 | +0,19 % | Arcturus Therapeutics Holdings Inc.: Arcturus Therapeutics to Present at Jefferies London Healthcare Conference | Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities... ► Artikel lesen | |
| ASSERTIO | 0,950 | 0,00 % | Assertio Holdings-Direktorin Heather Mason kauft Aktien im Wert von 60.000 US-Dollar | ||
| SIGA TECHNOLOGIES | 6,250 | 0,00 % | SIGA Technologies - TPOXX chalks up another DoD contract win | SIGA Technologies announced another contract win with the US Department of Defense (DoD), which is for the procurement of c $9m in TPOXX. This is the third DoD contract win in roughly three years for... ► Artikel lesen | |
| ADMA BIOLOGICS | 21,470 | +0,47 % | Adma Biologics Aktie: Erholung nach starkem Kursrückgang | ||
| VIR BIOTECHNOLOGY | 6,645 | -1,41 % | Needham & Company LLC Reaffirms Buy Rating for Vir Biotechnology (NASDAQ:VIR) | ||
| VERVE THERAPEUTICS | 4,565 | +0,33 % | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on October 31, 2024... ► Artikel lesen | |
| TRAVERE THERAPEUTICS | 17,000 | 0,00 % | Kidney Disease Leader Travere Therapeutics Pulls Back To Key Level | ||
| ARVINAS | 22,650 | -0,18 % | Arvinas, Inc. (ARVN): This Small-Cap Stock Is Ready To Explode | ||
| BIO-PATH | 0,790 | 0,00 % | Bio-Path Holdings, Inc.: Bio-Path Holdings Reports Third Quarter 2024 Financial Results | Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology... ► Artikel lesen |
RAPID MICRO BIOSYSTEMS INC gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 1,100 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPID MICRO BIOSYSTEMS INC finden Sie auf Wallstreet Online.
